Artal Group S.A. - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 152 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$7,795,000
+141.9%
574,000
+35.1%
0.22%
+60.3%
Q1 2020$3,222,000
+20.0%
425,0000.0%0.14%
+30.8%
Q4 2019$2,686,000
+61.2%
425,0000.0%0.10%
+55.2%
Q3 2019$1,666,000
-19.0%
425,0000.0%0.07%
-19.3%
Q2 2019$2,057,000
-47.1%
425,000
-10.5%
0.08%
-47.8%
Q1 2019$3,890,000
+48.1%
475,0000.0%0.16%
+63.9%
Q4 2018$2,627,000
-37.4%
475,0000.0%0.10%
-11.0%
Q3 2018$4,194,000
-11.5%
475,0000.0%0.11%
+7.9%
Q2 2018$4,741,000
+4.7%
475,0000.0%0.10%
+77.2%
Q1 2018$4,527,000475,0000.06%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Worth Venture Partners, LLC 63,500$46,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders